Overview of the FTC’s Proposed Settlement with Express Scripts
On February 4, 2026, the Federal Trade Commission accepted a consent agreement for public comment regarding a settlement with Express Scripts, Inc. and its affiliated entities (collectively “ESI”). Once the consent order is issued by the Commission, it carries the force of law. The settlement resolves the lawsuit filed by the Commission against ESI regarding […]
What is a PBM Audit & Why You Might Need One in 2026
While PBM arrangements remain complex, the real question for organizations heading into 2026 is clear: How do you ensure your contracts are performing as promised? Hear from Ethica Pharmacy Advisors as we break down what a pharmacy benefits audit really is and why it’s one of the most powerful tools employers need to take control […]
Preparing for PBM Transparency Mandates: What Employers Must Know About New Federal Compliance Rules
Recent legislative and regulatory updates are shaping new PBM transparency and disclosure requirements, and Ethica Pharmacy Advisors is here to outline the compliance considerations for employers. On January 30, 2026, the Department of Labor (DOL) released proposed rules (“Improving Transparency into Pharmacy Benefit Manager Fee Disclosure”) developed pursuant to Executive Order 14273 and supported under […]
What Illinois’ Prescription Drug Affordability Act Means for PBM Contracts
Ethica State Law Alert On July 1, 2025, Illinois House Bill 1697, also known as the Prescription Drug Affordability Act, was signed into law. Key provisions of this Act applicable to employer sponsored group health plans and Pharmacy Benefit Manager (PBM) contracts, including PBM audit and transparency requests, are effective as of January 1, 2026. […]
When “Simpler Pricing” Still Means Complexity
Recent headlines are drawing attention to the opacity of pharmacy benefit managers (PBMs), as policymakers, employers, and the media increasingly question how drug prices are set and who truly benefits.
Departments Announce Nonenforcement Policy for September 2024 Final Mental Health Parity Regulations
On May 15, 2025, the Departments of Labor, Health and Human Services and the Treasury announced they will not enforce the September 2024 regulations implementing the NQTL comparative analysis requirement under the Mental Health Parity and Addiction Equity Act as required by the Consolidated Appropriations Act, 2021.
GLP-1s: Balancing Costs and Benefits
Obesity happens when your body stores too much fat, to the point where it can affect your health. It’s typically measured using BMI (body mass index), which is calculated by dividing your weight by the square of your height.
The Complexities Surrounding GLP-1 Agonist Drugs
The conversation around the cost and coverage of GLP-1 agonist (or GLP-1s) drugs for weight loss is one we frequently have with our clients.
Let’s make it make sense.
Pharmacy benefits clarity begins with our market analysis where we reveal data-driven insights and identify opportunities to help you make more informed decisions.